Interferon-alpha and its effects on the cytokine cascade: A pro- and anti-inflammatory cytokine

Leukemia and Lymphoma

Volumn 23, Issue 1-2, 1996, Pages 55-60

  Tilg, Herbert ^a   Peschel, Christian ^b  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Anti inflammatory; Cytokine; Cytokine cascade; Interferon alpha; Pro inflammatory

Indexed keywords

ALPHA INTERFERON; ANTIINFLAMMATORY AGENT; CYTOKINE; HEMOPOIETIC GROWTH FACTOR; IMMUNOMODULATING AGENT; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; CYTOKINE PRODUCTION; HEMATOPOIESIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029844725     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054802     Document Type: Review

References (73)

1. Isaacs, A. and Lindemann, J. (1957) Virus interference. I. The interferon. Proc. R. Acad Britain, 147, 258-267.
2. Finter, N. B., Chapman, S., Dowd, P , et al. (1991) The use of interferon-α in virus infections. Drugs, 42, 749-761.
3. Talpaz, M., Kantarjian, H., Kurzrock, R., Trujillo, J. M. and Guttermann, J U (1991) Interferon-alpha produces sustained cytogenetic responses in chronic myelogeneic leukemia Ann. Intern. Med , 114, 532-538.
4. Di Bisceglie, A. M., Martin, P., Kassianides, C., et al. (1989) Recombinant interferon alpha therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N. Engl. J. Med., 321, 1506-1511.
5. Mitsuyasu, R. T. (1991) Use of recombinant interferons and hematopoietic growth factors in patients infected with human immunodeficiency virus. Rev. Infect Dis., 13, 979-991
6. Volz, M. A. and Kirkpatrick, C. H. (1992) Interferons 1992. How much of the promise has been realized? Drugs. 43, 285-294.
7. Borden, E. C. (1992) Interferons-expanding therapeutic roles. N. Engl. J. Med., 326, 1491-1493.
8. Guttermann, J. U. (1995) Cytokine therapeutics: Lessons from interferon α. Proc. Natl. Acad. Sci., 91, 1198-1205
9. Sacchi, S., Kantarjian, H., O'Brien, S., Cohen, P. R., Pirce, S. and Talpaz, M. (1995) Immune-mediated and unsusual complications during interferon alfa therapy in chronic myelogenous leukemia. J. Clin. Oncol. 13, 2401-2407.
10. Kiely, P. D. and Bruckner, F. E. (1994) Acute arthritis following interferon-alpha therapy. Br J. Rheumatol., 33, 502-503.
11. Sugano, S., Yanagimoto, M., Suzuki, T., et al. (1994) Retinal complications with elevated circulating plasma C5a associated with interferon-alpha therapy for chronic active hepatitis C. Am. J. Gastroenterol., 89, 2054-2056.
12. Sotomatsu, M., Shimoda, M., Ogawa, C. and Morikawa, A. (1995) Acute pancreatitis associated with interferon-alpha therapy for chronic myelogenous leukemia. Am. J. Hematol., 48, 211-212.
13. Durand, J.M., Retornaz, F., Cretel, E., Kaplanski, G. and Souberand, J. (1995) Cresentic glomerulonephritis during treatment with interferon-alpha 2b. Am. J. Hematol., 48, 140-141.
14. Stewart, T. A., Hultgren, B., Huang, X., et al. (1993) Induction of type I diabetes by interferon-alpha in transgenic mice. Science, 260, 1942-1946.
15. Hladik, F., Tratkiewicz, J., Tilg, H., et al. (1994) Biologic activity of low dosage IL-2 treatment in vivo. J. Immunol., 153, 1449-1454.
16. Aulitzky, W. G., Gastl, G., Aulitzky, W E., et al. (1989) Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-γ. J. Clin. Oncol., 7, 1875-1882.
17. + T cells. J. Exp. Med., 178, 1655-1663.
18. Dinarello, C. A. (1994) The interleukin-1 family: 10 years of discovery. FASEB J., 8, 1314-1325.
19. Carter, D. B., Deibel, M. R. J., Dunn, C. J , et al. (1990) Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature, 344, 633-638.
20. Eisenberg, S., Brewer, M T., Verderber, E., Heimdal, P., Brandhuber, B. J. and Thompson, R. C. (1991) IL-1 receptor antagonist is a member of the EL-1 gene family. Proc. Natl. Acad. Sci., 88, 5232-5236.
21. Schindler, R., Ghezzi, P. and Dinarello, C. A. (1990) IL-1 induces IL-1, IV, IFNγ suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. J. Immunol., 144, 2216-2222.
22. Tilg, H., Mier, J. W., Vogel, W., et al (1993) Induction of circulating IL-1 receptor antagonist by IFN treatment. J. Immunol., 150, 4687-4692.
23. Huang, Y., Blatt, L. M. and Tylor, M. W. (1995) Type I interferon as an antiinflammatory agent: Inhibition of lipopolysaccharide-induced interleukin-1β and induction of interleukin-1 receptor antagonist. J. Interferon Cytokine Res , 15, 317-321.
24. Aulitzky, W. E., Peschel, C., Despres, D., et al. (1993) Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemia. Ann. Hematol., 67, 205-211.
25. Oliviera, I. C., Scuavolino, P. J., Lee, T. H and Vilcek, J (1992) Downregulation of interleukin-8 gene expression in human fibroblasts: Unique mechanism of transcriptional inhibition by interferon. Proc. Natl. Acad. Sci., 89, 9043-9048.
26. Aman, M. I., Rudolf, G., Goldschmitt, G., et al. (1993) Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells. Blood, 82, 2371-2382.
27. Beutler, B. and Cerami, A. (1989) The biology of cachectin/TNF - A primary mediator of the host response. Ann. Rev. Immunol., 7, 625-638.
28. Olsson, I., Gatanaga, T., Gullberg, U., Lantz, M. and Granger, G. A. (1993) Tumour necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy. Eur Cytokine Netw., 4, 169-178.
29. Abu-Khabar, K. S., Armstrong, J A. and Ho, M. (1992) Type I interferons (IFN-alpha and -beta) suppress cytotoxin (tumor necrosis factor-alpha and lymphotoxin) production by mitogen-stimulated human peripheral blood mononuclear cells. J. Leukoc. Biol.. 52, 165-172.
30. Romquin, N. and Billard, C. (1995) Autocrine loop of tumor necrosis factor induced by interferon-alpha in tumor cells from hairy cell leukemia. Leukemia, 9, 87-94.
31. Garcia-Monzon, C., Garcia-Buey, L., Garcia-Sanchez, A., Pajares, J. M. and Moreno-Otero, R. (1993) Down-regulation of intercellular adhesion molecute 1 on hepatocytes in viral chronic hepatitis treated with interferon alfa 2-b. Gastroenterology, 105, 462-470.
32. Tzung, S. P., Mahl, T. C., Lance, P., Andersen, V. and Cohen, S. A. (1993) Interferon-alpha prevents endotoxin-induced mortality in mice. Eur. J. Immunol., 22, 3097-3104.
33. Tilg, H., Vogel, W. and Dinarello, C. A. (1995) Interferon-α induces circulating tumor necrosis factor receptor p55 in humans. Blood, 85, 433-435.
34. Aggarwal, B. B. and Pandita, R. (1994) Both type I and type II interferons down-regulate human tumor necrosis factor receptors in human hepatocellular carcinoma cell line Hep G2. Role of protein kinase C FEBS - Lett., 337, 99-102.
35. Moore, K. V., O'Garra, A., de Waal Malefyt, R., Vieira, P. and Mosmann, T. R. (1993) Interleukin-10. Ann. Rev. Immunol., 11, 165-179.
36. Arnason, B. G. W. (1993) Neurology, 43, 641-643.
37. Huber, C., Batchelor, R., Fuchs, D., et al. (1984) Immune response associated production of neopterin: release from macrophages primarily under control of interferon gamma. J. Exp. Med., 160, 310-315.
38. Gisslinger, H., Svoboda, T., Caodi, M., et al. (1993) Interferon-alpha stimulates the hypothalamic-pituitary-adrenal axis in vivo and in vitro. Neuroendocrinology, 57, 489-495.
39. Kühn, R., Lohler, J., Rennick, D., Rajewsky, K. and Müller, W. (1993) Interleukin-10 deficient mice develop chronic enterocolitis. Cell, 75, 263-274.
40. Cohen, R. D. and Hanauer, S. B. (1995) Immunomodulatory agents and other medical therapies in inflammatory bowel diseases. Curr. Op. Gastroenterol., 11, 321-330.
41. Gasche, C., Reinisch, W , Wirth, H. P., et al. (1994) Treatment of chronic active Crohn's disease with interferon alpha. Gasiroemerology, 106, A685.
42. Ensoli, B., Nakamura, S., Saiahuddin, Z., et al (1989) AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects Science, 243, 223-226.
43. Muller, C., Bergmann, K. F., Gerin, J. L. and Korba, B. E. (1992) Production of hepatitis B virus by stably transfected monocytic cell line: a model forextrahepatic hepatitis B virus replication. J. Infect. Dis., 165, 929-935.
44. Granowitz, E. V., Saget, B. M., Wang, M. Z., Dinarello, C. A. and Skolmk, P. R (1995) Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: Blockade by interleukin-1 receptor antagonist and tumor necrosis factor binding protein type 1. Molecular Medicine, 1, 667-677.
45. Poli, G., Kinter, A. L. and Fauci, A S. (1994) Interleukin-1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc. Natl. Acad. Sci., 91, 108-112.
46. Arai, K., Lee, F., Miyajima, A., Miyatake, S , Arai, N. and Yokota, T. (1990) Cytokines, coordinators of immune and inflammatory responses. Annu. Rev. Biochem , 59, 783-836.
47. Ogawa, M. (1993) Differentiation and proliferation of hematopoietic stem cells. Blood, 81, 2844-2853.
48. Mochizuki, D. Y., Eisenman, J. F., Conlon, P. J., Larsen, A. D. and Tushmski, R. J. (1987) Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1. Proc Natl. Acad. Sci. USA, 84, 5267-5272.
49. Yang, Y.-C. Tsai, S., Wong, G G. and Clark, S. C. (1988) Interleukin-1 regulation of hematopoietic growth factor production by human stromal fibrablasts. J. Cell Physiol. 134, 292-299.
50. Fibbe, W. E., Gosenlink, H. M., Van Eeden, G., Van Damme, J., Biliau, A., Voogt, P. J., Willemze, R. and Falkenburg, J. H. F. (1988) Proliferation of myeloid progenitor cells in human long-term bone marrow cultures is stimulated by interleukin-1 beta. Blood, 72, 1242-1250.
51. Van Damme, J., Opdenakker, G., Simpson, R. J., Rubira, M. R., Cayphas, S., Vink, A., Biliau, A. and Van Snick, J. (1987) Identification of the human 26 kD protein, interferon 52 (IFN-b2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J. Exp. Med., 165, 914-922.
52. Elias, J. A., Zheng, T., Whiting, N. L., Trow, T. K., Merrill, W. W., Zitnik, R., Ray, P. and Alderman, E. M. (1994) IL-1 and transforming growth factor-beta regulation of fibroblast-derived IL-11. J. Immunol., 152, 2421-2429.
53. Yang, L. and Yang, Y. C. (1994) Regulation of interleukin (IL)-11 gene expression in IL-1 induced primate bone marrow stromal cells. J. Biol. Chem., 269, 32732-32739.
54. Aye, M. T., Hashemi, S., Leclair, B., Zeibdawi, A., Trudel, E., Halpenny, M., Fuller, V. and Cheng, G. (1992) Expression of stem cell factor and c-kit mRNA in cultured endothelial cells, monocytes and cloned human bone marrow cells (CFU-RF). Exp. Hematol., 20, 523-527.
55. Koenig, A., Yakisan, E., Reuter, M., Huang, M., Sykora, K. W., Corbacioglu, S. and Weite, K. (1994) Differential regulation of stem cell factor mRNA expression in human endothelial cells by bacterial pathogens: an in vitro model of inflammation. Blood, 83, 2836-2843.
56. Kantarjian, H. M., Deisseroth, A., Kurzrock, R., Estrov, Z. and Talpaz, M. (1993) Chronic myelogenous leukemia: A concise update. Blood, 82, 691-703.
57. Aulitzky, W. E., Peschel, C., Schneller, F. and Huber, C. (1995) Biotherapy of chronic myelogenous leukemia. Ann. Hematol., 70, 113-120
58. Silver, R. T. (1990) A new treatment for polycythemia vera: Recombinant interferon alpha. Blood, 76, 664-665.
59. Giles, F. J., Singer, C. R., Gray, A. G., Yong, K. L., Brozovic, M., Davies, S. C., Grant, I. R., Hoffbrand, A. V., Machin, S. J. and Mehta, A. B. (1988) Alpha-interferon therapy for essential thrombocythaemia. Lancet, 2, 70-72.
60. Vilcek, J. (1990) In Peptide growth factors and their receptors II, edited by M. B. Sporn and A. B. Roberts, pp. 3-42 New York. N. Y Springer Verlag
61. Broxmeyer, H. E., Lu, L., Platzer, E., Feit, C., Juliano, L and Rubin, B. Y. (1983) Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-e) and granulocyte-macrophage (CFU-GM) progenitor cells. J. Immunol. 131, 1300-1305.
62. Raefsky, E. L , Platanias, L. C., Zoumbos, N. C. and Young, N. S. (1985) Studies of interferon as a regulator of hematopoietic cell proliferation. J. Immunol., 135, 2507-2512.
63. Ganser, A., Carlo-Stella, C., Greher, J., Völkers, B. and Hoelzer, D. (1987) Effect of recombinant interferons alpha and gamma on human bone marrow-derived mesakaryocytic progenitor cells. Blood, 70, 1173-1179.
64. Geissler, D., Gastl, G., Aulitzky, W. E., Tilg, H., Gaggl, S , Konwalinka, G. and Huber, C. (1990) Recombinant interferon alpha-2c in chronic myelogenous leukemia: relationship of sensitivity of committed haematopoietic precursor cells in vitro. Leuk Res., 14, 629-636.
65. Dowding, C., Guo, A. P., Maisin, D., Gordon, M. Y. and Goldman, J. M. (1991) The effects of interferon-alpha on the proliferation of CML progenitor cells in vitro are not related to the precise position of the M-BCR breakpoint. Brit J. Haematol. 77, 165-171.
66. Mazur, E. M., Richtsmeier, W. J. and South, K. (1986) Alpha-interferon: differential suppression of colony growth from human erythroid, myeloid, and megakaryocytic hemopoietic progenitor cells. J. Interferon Res., 6, 199-206.
67. Galvani, D. W. and Cawley, J. C. (1989) Mechanism of action of alpha interferon in chronic granulocytic leukaemia: evidence for preferential inhibition of late progenitors. Brit. J. Haematol., 73, 475-479.
68. Després, D., Goldschmitt, J., Aulitzky, W. E., Huber, C. and Peschel, C. (1995) Differential effect of type I interferons on hematopoietic progenitor cells Failure of IFNs to inhibit immaturemyeloid progenitor cells from normal bone marrow and chronic myelogeneous leukemia. Exp. Hematol. (in press).
69. Aman, M. J., Keller, U., Derigs, G., Mohamadzadeh, M., Huber, C. and Peschel, C. (1994) Regulation of cytokine expression by interferon alpha in human bone marrow stromal cells: Inhibition of hematopoietic growth factors and induction of IL-1 receptor antagonist. Blood, 83, 4142-4150.
70. Du, X. X., Doerschuk, C. M , Orazi, A. and Williams, D. A. (1994) A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood, 83, 33-37.
71. Aman, M. J., Bug, G., Huber, C and Peschel, C. (1995) Inhibition of interleukin-11 by interferon-alpha in human bone marrow stromal cells. Exp. Hematol. (in press).
72. Graham, G. J., Wright, E. G., Hewick, R , Wolpe, S. D., Wilkie, N. M., Donaldson, D., Lorimore, S. and Pragnell, I. B. (1990) Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature, 344, 442-444.
73. Peschel, C., Bug, G., Aman, M. J., Derigs, G. and Huber, C. (1995) Tissue specific regulation of the expression of macrophage inflammatory protein 1a (MIP-1a). Exp. Hematol , 23, 93 (Abs).